NLRP3 and metabolic dysfunction-associated steatohepatitis: NASH is characterized by lipotoxicity which could result in release of DAMPs from injured hepatocytes, while leaky gut and microbiome dysregulation could result in PAMPs, including lipopolysaccharide, potentially triggering NLRP3 activation.